Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023

Publisher Name :
Date: 05-Apr-2018
No. of pages: 193
Inquire Before Buying

“The sepsis diagnostics market projected to grow at a CAGR of 9.1%.”

The global sepsis diagnostics market is projected to reach USD 613.9 million by 2023 from USD 396.6 million in 2018, at a CAGR of 9.1%. Rising incidence of sepsis, rising geriatric population, growing number of surgical procedures, high incidence of hospital-acquired infections, and commercialization and availability of a wide variety of approved sepsis diagnostic devices are the factors expected to drive the market during the study period. However, the lack of established reimbursement policies for sepsis and high cost of automated diagnostic devices are the major factors restraining the growth of this market.

“Microbiology to command the largest share of the sepsis diagnostics market in 2018.”

On the basis of technology, the microbiology segment is expected to command the largest share of the global sepsis diagnostics market in 2018. The large share of this segment can be attributed to the growing use of blood culture techniques for the diagnosis of sepsis.

“The blood culture media segment is expected to be the fastest-growing segment during the forecast period.”

On the basis of products, the market is segmented into blood culture media, instruments, assays & reagents, and software. The blood culture media segment is expected to be the fastest-growing segment during the forecast period. The large share of this segment can be attributed to the fact that blood culture testing is used as the standard diagnostic method for the diagnosis and identification of sepsis across the globe.

“Asia Pacific is expected grow at the highest CAGR during the forecast period.”

Geographically, the sepsis diagnostics market is segmented into North America, Europe, Asia Pacific, and RoW. Asia Pacific is expected to register the highest growth rate during the forecast period d ue to the high prevalence of sepsis, increasing number of surgical procedures, growing number of clinical studies, and developing healthcare infrastructure in this region.

Breakdown of supply-side primary interviews:


  • By Company Type - Tier 1 – 30%, Tier 2 – 55% and Tier 3 – 15%

  • By Designation – C-level – 30%, Director-level – 35%, Others – 35%

  • By Region – North America - 55%, Europe – 15%, APAC – 25%, RoW – 5%


The major players of the sepsis diagnostics market arebio Mérieux (France), T2 Biosystems (US), Luminex (US), Thermo Fisher Scientific (US), Bruker (US),Abbott (US), Roche (Switzerland), Danaher (US), Becton, Dickinson, and Company (US), EKF Diagnostics (UK), Immunexpress (Australia), Response Biomedical (Canada), Axis-Shield Diagnostics (UK), CytoSorbents (US), and Mitsubishi Chemical Europe (Germany).

Research Coverage

This report studies the sepsis diagnostics market based on technology, product, pathogen, test type, method, end user, and region. The report studies factors affecting market growth, analyzes opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the study analyzes micro markets with respect to their individual growth trends. The research report forecasts the revenue of market segments with respect to the four key regions and respective countries.

Reasons to Buy the Report:

From an insights perspective, this research report has focused on various levels of analysis—market ranking analysis of top players and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging segments of the sepsis diagnostics market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, will help firms garner greater market shares.

Sepsis Diagnostics Market by Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), Product (Blood Culture Media, Instruments), Method (Automated), Test Type (Lab, POC), Pathogen (Bacterial, Fungal), End-User - Global Forecast to 2023

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Markets Covered
1.4.1 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.3 Market Size Estimation Methodology
2.1.4 Bottom-Up Approach
2.1.5 Top-Down Approach
2.1.6 Research Design
2.1.7 Market Data Validation and Triangulation
2.1.8 Assumptions for the Study

3 Executive Summary

4 Premium Insights
4.1 Sepsis Diagnostics: Market Overview
4.2 Sepsis Diagnostic Market, By Technology
4.3 Geographic Analysis: Sepsis Diagnostics Market, By Product and Region
4.4 Sepsis Diagnostic Market, By Pathogen
4.5 Sepsis Diagnostic Market, By Method
4.6 Geographic Snapshot of the Sepsis Diagnostics Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Incidence of Sepsis in the Adult Population
5.2.1.1 Increasing Incidence of Sepsis in Neonates
5.2.1.2 Growing Incidence of Hospital-Acquired Infections
5.2.1.3 Increasing Number of Surgical Procedures
5.2.1.4 Increasing Burden of Pneumonia
5.2.1.5 Influx of Novel Sepsis Diagnostic Products
5.2.1.6 Rising Initiatives to Increase the Awareness and Drive the Adoption of Sepsis Diagnostic Tests
5.2.1.7 Funding for Sepsis-Related Research Activities
5.2.2 Restraints
5.2.2.1 Lack of Established Reimbursement Policies for Sepsis
5.2.2.2 High Cost of Automated Diagnostic Devices
5.2.3 Opportunities
5.2.3.1 Development of Rapid Diagnostic/POC Techniques for Early Sepsis Diagnosis
5.2.3.2 Evolution of Novel Biomarkers for Sepsis Diagnosis
5.2.4 Challenges
5.2.4.1 Lack of Standard Protocols and Awareness for Sepsis Diagnosis and Treatment
5.2.4.2 Shortage of Skilled Healthcare Professionals

6 Sepsis Diagnostics Market, By Technology
6.1 Introduction
6.2 Microbiology
6.3 Molecular Diagnostics
6.3.1 Polymerase Chain Reaction
6.3.2 Peptide Nucleic Acid-Fluorescent in Situ Hybridization
6.3.3 Microarrays
6.3.4 Syndromic Panel-Based Testing
6.4 Immunoassay
6.5 Flow Cytometry
6.6 Microfluidics
6.7 Biomarkers

7 Sepsis Diagnostics Market, By Product
7.1 Introduction
7.2 Instruments
7.3 Blood Culture Media
7.4 Assays & Reagents
7.5 Software

8 Sepsis Diagnostics Market, By Method
8.1 Introduction
8.2 Conventional Diagnostics
8.3 Automated Diagnostics

9 Sepsis Diagnostics Market, By Pathogen
9.1 Introduction
9.2 Bacterial Sepsis
9.2.1 Gram-Negative Bacterial Sepsis
9.2.2 Gram-Positive Bacterial Sepsis
9.3 Fungal Sepsis
9.4 Other Pathogens

10 Sepsis Diagnostics Market, By Test Type
10.1 Introduction
10.2 Laboratory Tests
10.3 Point-Of-Care Tests

11 Sepsis Diagnostics Market, By End User
11.1 Introduction
11.2 Hospitals
11.3 Pathology & Reference Laboratories

12 Sepsis Diagnostics Market, By Region
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.3 Europe
12.3.1 Germany
12.3.2 France
12.3.3 UK
12.3.4 Rest of Europe (RoE)
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Rest of Asia Pacific
12.5 Rest of the World
12.5.1 Latin America
12.5.2 Middle East & Africa

13 Competitive Landscape
13.1 Overview
13.2 Market Share Analysis
13.3 Competitive Scenario
13.3.1 Product Launches and Approvals, 2015–2017
13.3.2 Partnerships and Collaborations, 2015–2018
13.3.3 Mergers and Acquisitions

14 Company Profiles
(Business Overview, Products Offered, Recent Developments, MnM View)*
14.1 Biomérieux
14.2 T2 Biosystems
14.3 Luminex
14.4 Becton, Dickinson, and Company (BD)
14.5 Roche Diagnostics (A Subsidiary of F. Hoffmann-LA Roche Ltd.)
14.6 Danaher
14.7 Thermo Fisher Scientific
14.8 Bruker
14.9 Abbott
14.10 Immunexpress
14.11 Response Biomedical
14.12 Axis-Shield Diagnostics
14.13 Cytosorbents
14.14 Mitsubishi Chemical Europe
14.15 EKF Diagnostics

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

15 Appendix
15.1 Discussion Guide
15.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
15.3 Introducing RT: Real-Time Market Intelligence
15.4 Available Customizations
15.5 Related Reports
15.6 Author Details

List of Tables

Table 1 Sepsis Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 2 Microbiology Market for Sepsis Diagnosis, By Region, 2016–2023 (USD Million)
Table 3 Molecular Diagnostics Market for Sepsis Diagnosis, By Region, 2016–2023 (USD Million)
Table 4 Immunoassay Market for Sepsis Diagnosis, By Region, 2016–2023 (USD Million)
Table 5 Flow Cytometry Market for Sepsis Diagnosis, By Region, 2016–2023 (USD Million)
Table 6 Microfluidics Market for Sepsis Diagnosis, By Region, 2016–2023 (USD Million)
Table 7 Biomarkers Market for Sepsis Diagnosis, By Region, 2016–2023 (USD Million)
Table 8 Sepsis Diagnostic Market, By Product, 2016–2023 (USD Million)
Table 9 Sepsis Diagnostic Instruments Market, By Region, 2016–2023 (USD Million)
Table 10 Sepsis Diagnostic Blood Culture Media Market, By Region, 2016–2023 (USD Million)
Table 11 Sepsis Diagnostic Assays & Reagents Market, By Region, 2016–2023 (USD Million)
Table 12 Sepsis Diagnostic Software Market, By Region, 2016–2023 (USD Million)
Table 13 Sepsis Diagnostics Market, By Method, 2016–2023 (USD Million)
Table 14 Conventional Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 15 Automated Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 16 Sepsis Diagnostic Market, By Pathogen, 2016–2023 (USD Million)
Table 17 Bacterial Sepsis Market, By Type, 2016–2023 (USD Million)
Table 18 Bacterial Sepsis Market, By Region, 2016–2023 (USD Million)
Table 19 Bacterial Causes of Adult Sepsis
Table 20 Bacterial Causes of Adult Sepsis
Table 21 Fungal Sepsis Market, By Region, 2016–2023 (USD Million)
Table 22 Other Pathogens Market, By Region, 2016–2023 (USD Million)
Table 23 Sepsis Diagnostics Market, By Test Type, 2016–2023 (USD Million)
Table 24 Laboratory Pointers of Sepsis
Table 25 Laboratory Tests Market, By Region, 2016–2023 (USD Million)
Table 26 Point-Of-Care Tests Market, By Region, 2016-2023 (USD Million)
Table 27 Sepsis Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 28 Sepsis Diagnostic Market for Hospitals, By Region, 2016–2023 (USD Million)
Table 29 Sepsis Diagnostics Market for Pathology & Reference Laboratories, By Region, 2016–2023 (USD Million)
Table 30 Sepsis Diagnostic Market, By Region, 2016–2023 (USD Million)
Table 31 North America: Sepsis Diagnostics Market, By Country, 2016–2023 (USD Million)
Table 32 North America: Sepsis Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 33 North America: Sepsis Diagnostics Market, By Product, 2016–2023 (USD Million)
Table 34 North America: Sepsis Diagnostic Market, By Pathogen, 2016–2023 (USD Million)
Table 35 North America: Sepsis Diagnostics Market, By Method, 2016–2023 (USD Million)
Table 36 North America: Sepsis Diagnostics Market, By Test Type, 2016–2023 (USD Million)
Table 37 North America: Sepsis Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 38 US: Sepsis Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 39 US: Sepsis Diagnostics Market, By Product, 2016–2023 (USD Million)
Table 40 US: Sepsis Diagnostic Market, By Pathogen, 2016–2023 (USD Million)
Table 41 US: Sepsis Diagnostics Market, By Method, 2016–2023 (USD Million)
Table 42 US: Sepsis Diagnostic Market, By Test Type, 2016–2023 (USD Million)
Table 43 US: Sepsis Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 44 Canada: Sepsis Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 45 Canada: Sepsis Diagnostics Market, By Product, 2016–2023 (USD Million)
Table 46 Canada: Sepsis Diagnostic Market, By Pathogen, 2016–2023 (USD Million)
Table 47 Canada: Sepsis Diagnostics Market, By Method, 2016–2023 (USD Million)
Table 48 Canada: Sepsis Diagnostic Market, By Test Type, 2016–2023 (USD Million)
Table 49 Canada: Sepsis Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 50 Europe: Sepsis Diagnostic Market, By Country, 2016–2023 (USD Million)
Table 51 Europe: Sepsis Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 52 Europe: Sepsis Diagnostic Market, By Product, 2016–2023 (USD Million)
Table 53 Europe: Sepsis Diagnostics Market, By Pathogen, 2016–2023 (USD Million)
Table 54 Europe: Sepsis Diagnostic Market, By Method, 2016–2023 (USD Million)
Table 55 Europe: Sepsis Diagnostics Market, By Test Type, 2016–2023 (USD Million)
Table 56 Europe: Sepsis Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 57 Germany: Sepsis Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 58 Germany: Sepsis Diagnostic Market, By Product, 2016–2023 (USD Million)
Table 59 Germany: Sepsis Diagnostics Market, By Pathogen, 2016–2023 (USD Million)
Table 60 Germany: Sepsis Diagnostic Market, By Method, 2016–2023 (USD Million)
Table 61 Germany: Sepsis Diagnostics Market, By Test Type, 2016–2023 (USD Million)
Table 62 Germany: Sepsis Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 63 France: Sepsis Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 64 France: Sepsis Diagnostic Market, By Product, 2016–2023 (USD Million)
Table 65 France: Sepsis Diagnostics Market, By Pathogen, 2016–2023 (USD Million)
Table 66 France: Sepsis Diagnostic Market, By Method, 2016–2023 (USD Million)
Table 67 France: Sepsis Diagnostics Market, By Test Type, 2016–2023 (USD Million)
Table 68 France: Sepsis Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 69 UK: Sepsis Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 70 UK: Sepsis Diagnostic Market, By Product, 2016–2023 (USD Million)
Table 71 UK: Sepsis Diagnostics Market, By Pathogen, 2016–2023 (USD Million)
Table 72 UK: Sepsis Diagnostic Market, By Method, 2016–2023 (USD Million)
Table 73 UK: Sepsis Diagnostics Market, By Test Type, 2016–2023 (USD Million)
Table 74 UK: Sepsis Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 75 RoE: Sepsis Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 76 RoE: Sepsis Diagnostic Market, By Product, 2016–2023 (USD Million)
Table 77 RoE: Sepsis Diagnostics Market, By Pathogen, 2016–2023 (USD Million)
Table 78 RoE: Sepsis Diagnostic Market, By Method, 2016–2023 (USD Million)
Table 79 RoE: Sepsis Diagnostics Market, By Test Type, 2016–2023 (USD Million)
Table 80 RoE: Sepsis Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 81 APAC: Sepsis Diagnostics Market, By Country, 2016–2023 (USD Million)
Table 82 APAC: Sepsis Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 83 APAC: Sepsis Diagnostics Market, By Product, 2016–2023 (USD Million)
Table 84 APAC: Sepsis Diagnostic Market, By Pathogen, 2016–2023 (USD Million)
Table 85 APAC: Sepsis Diagnostics Market, By Method, 2016–2023 (USD Million)
Table 86 APAC: Sepsis Diagnostic Market, By Test Type, 2016–2023 (USD Million)
Table 87 APAC: Sepsis Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 88 Japan: Sepsis Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 89 Japan: Sepsis Diagnostics Market, By Product, 2016–2023 (USD Million)
Table 90 Japan: Sepsis Diagnostic Market, By Pathogen, 2016–2023 (USD Million)
Table 91 Japan: Sepsis Diagnostics Market, By Method, 2016–2023 (USD Million)
Table 92 Japan: Sepsis Diagnostic Market, By Test Type, 2016–2023 (USD Million)
Table 93 Japan: Sepsis Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 94 China: Sepsis Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 95 China: Sepsis Diagnostics Market, By Product, 2016–2023 (USD Million)
Table 96 China: Sepsis Diagnostic Market, By Pathogen, 2016–2023 (USD Million)
Table 97 China: Sepsis Diagnostics Market, By Method, 2016–2023 (USD Million)
Table 98 China: Sepsis Diagnostic Market, By Test Type, 2016–2023 (USD Million)
Table 99 China: Sepsis Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 100 India: Sepsis Diagnostic Market, By Technology, 2016–2023 (USD Million)
Table 101 India: Sepsis Diagnostics Market, By Product, 2016–2023 (USD Million)
Table 102 India: Sepsis Diagnostic Market, By Pathogen, 2016–2023 (USD Million)
Table 103 India: Sepsis Diagnostics Market, By Method, 2016–2023 (USD Million)
Table 104 India: Sepsis Diagnostic Market, By Test Type, 2016–2023 (USD Million)
Table 105 India: Sepsis Diagnostics Market, By End User, 2016–2023 (USD Million)
Table 106 RoAPAC: Sepsis Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 107 RoAPAC: Sepsis Diagnostics Market, By Product, 2016–2023 (USD Million)
Table 108 RoAPAC: Sepsis Diagnostic Market, By Pathogen, 2016–2023 (USD Million)
Table 109 RoAPAC: Sepsis Diagnostics Market, By Method, 2016–2023 (USD Million)
Table 110 RoAPAC: Sepsis Diagnostics Market, By Test Type, 2016–2023 (USD Million)
Table 111 RoAPAC: Sepsis Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 112 RoW: Sepsis Diagnostics Market, By Region, 2016–2023 (USD Million)
Table 113 RoW: Sepsis Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 114 RoW: Sepsis Diagnostic Market, By Product, 2016–2023 (USD Million)
Table 115 RoW: Sepsis Diagnostics Market, By Pathogen, 2016–2023 (USD Million)
Table 116 RoW: Sepsis Diagnostic Market, By Method, 2016–2023 (USD Million)
Table 117 RoW: Sepsis Diagnostics Market, By Test Type, 2016–2023 (USD Million)
Table 118 RoW: Sepsis Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 119 Latin America: Sepsis Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 120 Latin America: Sepsis Diagnostic Market, By Product, 2016–2023 (USD Million)
Table 121 Latin America: Sepsis Diagnostics Market, By Pathogen, 2016–2023 (USD Million)
Table 122 Latin America: Sepsis Diagnostic Market, By Method, 2016–2023 (USD Million)
Table 123 Latin America: Sepsis Diagnostics Market, By Test Type, 2016–2023 (USD Million)
Table 124 Latin America: Sepsis Diagnostic Market, By End User, 2016–2023 (USD Million)
Table 125 Middle East & Africa: Sepsis Diagnostics Market, By Technology, 2016–2023 (USD Million)
Table 126 Middle East & Africa: Sepsis Diagnostics Market, By Product, 2016–2023 (USD Million)
Table 127 Middle East & Africa: Sepsis Diagnostic Market, By Pathogen, 2016–2023 (USD Million)
Table 128 Middle East & Africa: Sepsis Diagnostics Market, By Method, 2016–2023 (USD Million)
Table 129 Middle East & Africa: Sepsis Diagnostic Market, By Test Type, 2016–2023 (USD Million)
Table 130 Middle East & Africa: Sepsis Diagnostics Market, By End User, 2016–2023 (USD Million)

List of Figures

Figure 1 Global Sepsis Diagnostics Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Data Triangulation Methodology
Figure 4 Global Sepsis Diagnostic Market, By Product, 2018
Figure 5 Global Sepsis Diagnostics Market, By Technology, 2023
Figure 6 Global Sepsis Diagnostic Market, By Method, 2018
Figure 7 Global Sepsis Diagnostic Market, By Test Type, 2018 vs 2023
Figure 8 Global Sepsis Diagnostics Market, By Pathogen, 2018
Figure 9 Global Sepsis Diagnostics Market, By End User, 2018
Figure 10 Global Sepsis Diagnostics Market, By Region, 2018 (USD Million)
Figure 11 Rising Prevalence of Sepsis is Driving the Growth of Sepsis Diagnostics Market Across the Globe
Figure 12 Microbiology Segment Will Continue to Dominate the Market in 2023
Figure 13 Blood Culture Media Segment to Dominate the Global Sepsis Diagnostics Products Market in 2018
Figure 14 Bacterial Sepsis Segment to Dominate the Sepsis Diagnostic Market During the Forecast Period
Figure 15 Conventional Diagnostics Method to Dominate the Sepsis Diagnostics Market During the Forecast Period
Figure 16 Asia Pacific to Register the Highest CAGR During the Forecast Period
Figure 17 Sepsis Diagnostic Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Biomarkers Segment to Witness the Highest Growth During the Forecast Period
Figure 19 Blood Culture Media Segment to Witness Highest Growth During the Forecast Period
Figure 20 Conventional Diagnostics Segment to Dominate the Sepsis Diagnostics Market in 2023
Figure 21 Bacterial Sepsis Segment to Register the Highest Growth Rate During the Forecast Period
Figure 22 Point-Of-Care Tests Segment to Grow at the Highest CAGR
Figure 23 Hospitals Segment to Dominate the Sepsis Diagnostics Market in 2023
Figure 24 Sepsis Incidence, By Country, 2017
Figure 25 Sepsis Diagnostic Market: Growth Forecast, By Region (2018–2023)
Figure 26 North America: Sepsis Diagnostics Market Snapshot
Figure 27 Europe: Sepsis Diagnostic Market Snapshot
Figure 28 APAC: Sepsis Diagnostic Market Snapshot
Figure 29 Key Developments By Leading Market Players in the Sepsis Diagnostics Market, 2015–2017
Figure 30 Sepsis Diagnostics Market Share, By Key Players, 2016
Figure 31 Biomérieux: Company Snapshot
Figure 32 T2 Biosystems: Company Snapshot
Figure 33 Luminex: Company Snapshot
Figure 34 BD: Company Snapshot
Figure 35 Roche Diagnostics: Company Snapshot
Figure 36 Danaher: Company Snapshot
Figure 37 Thermo Fisher Scientific: Company Snapshot
Figure 38 Bruker: Company Snapshot
Figure 39 Abbott: Company Snapshot
Figure 40 Cytosorbents: Company Snapshot
Figure 41 EKF Diagnostics: Company Snapshot

  • Global Toxicology Testing Market Professional Survey Report 2018
    Published: 18-Apr-2018        Price: US 3500 Onwards        Pages: 115
    This report studies Toxicology Testing in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2018, and forecast to 2025. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Agilent Technologies - Bio-Rad Laboratories - GE Healthcare - Cov......
  • 2018 France Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Volume and Sales Segment Forecasts, Business Environment, Market Structure
    Published: 09-Apr-2018        Price: US 4850 Onwards        Pages: 58
    This new report from VPGMarketResearch.com provides an overview of the French diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:     -  Blood Banking      -  Cancer      -  Chemistry     -  Coagulation     - ......
  • 2018 German Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Volume and Sales Segment Forecasts, Business Environment, Market Structure
    Published: 09-Apr-2018        Price: US 4850 Onwards        Pages: 61
    This new report from VPGMarketResearch.com provides an overview of the German diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:     -  Blood Banking      -  Cancer      -  Chemistry     -  Coagulation     - ......
  • 2018 Italian Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Volume and Sales Segment Forecasts, Business Environment, Market Structure
    Published: 09-Apr-2018        Price: US 4850 Onwards        Pages: 57
    This new report from VPGMarketResearch.com provides an overview of the Italian diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:     -  Blood Banking      -  Cancer      -  Chemistry     -  Coagulation     - ......
  • 2018 Japanese Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Volume and Sales Segment Forecasts, Business Environment, Market Structure
    Published: 09-Apr-2018        Price: US 4850 Onwards        Pages: 60
    This new report from VPGMarketResearch.com provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:     -  Blood Banking      -  Cancer      -  Chemistry     -  Coagulation     -&nbs......
  • 2018 Spain Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Volume and Sales Segment Forecasts, Business Environment, Market Structure
    Published: 09-Apr-2018        Price: US 4850 Onwards        Pages: 56
    This new report from VPGMarketResearch.com provides an overview of the Spanish diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:     -  Blood Banking      -  Cancer      -  Chemistry     -  Coagulation     - ......
  • 2018 UK Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Volume and Sales Segment Forecasts, Business Environment, Market Structure
    Published: 09-Apr-2018        Price: US 4850 Onwards        Pages: 64
    This new report from VPGMarketResearch.com provides an overview of the UK diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:     -  Blood Banking      -  Cancer      -  Chemistry     -  Coagulation     -  Dru......
  • 2018 US Diagnostics Market: Instrument and Reagent Supplier Shares by Test, Volume and Sales Segment Forecasts, Business Environment, Market Structure
    Published: 09-Apr-2018        Price: US 5400 Onwards        Pages: 101
    This new report from VPGMarketResearch.com provides an overview of the US diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments:     -  Blood Banking      -  Cancer      -  Chemistry     -  Coagulation     -  Dru......
  • Global Enzyme-Linked Immunosorbent Assay (ELISA) Market by Manufacturers, Countries, Type and Application, Forecast to 2023
    Published: 02-Apr-2018        Price: US 3480 Onwards        Pages: 102
    "Enzyme-linked immunosorbent assay (ELISA), also known as an enzyme immunoassay (EIA), is a biochemical technique used mainly in immunology to detect the presence of an antibody or an antigen in a sample. The ELISA has been used as a diagnostic tool in medicine and plant pathology, as well as a quality-control check in various industries,such as ELISA application in food industry. " Scope of the Report: This report focuses on the Enzyme-Linked Immunosorbent A......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs